0001345281-20-000007.txt : 20201120 0001345281-20-000007.hdr.sgml : 20201120 20201120171323 ACCESSION NUMBER: 0001345281-20-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201104 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY E GERALD CENTRAL INDEX KEY: 0001053310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 201333384 MAIL ADDRESS: STREET 1: C/O 225 LONG AVENUE CITY: HILLSIDE STATE: NJ ZIP: 07205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-11-04 0 0001016504 INTEGRATED BIOPHARMA INC inbp 0001053310 KAY E GERALD C/O 225 LONG AVENUE HILLSIDE NJ 07205 1 1 1 0 Executive Chairman & President Stock Option (right to buy) 0.72 2020-11-04 4 A 0 100000 0 A 2025-11-04 Common Stock 100000 100000 D The option vests in three equal annual installments beginning on November 4, 2021. /s/ E. Gerald Kay 2020-11-20